[Chronic neutrophilic leukemia/chronic eosinophilic leukemia].
Kawashima I, Kirito K.
Rinsho Ketsueki. 2023;64(10):1326-1334. doi: 10.11406/rinketsu.64.1326.
Chronic eosinophilic leukemia/hypereosinophilic syndrome.
Gotlib J.
Cancer Treat Res. 2008;142:69-106.
Updates on eosinophilic disorders.
Tzankov A, Reichard KK, Hasserjian RP, Arber DA, Orazi A, Wang SA.
Virchows Arch. 2023 Jan;482(1):85-97. doi: 10.1007/s00428-022-03402-8. Epub 2022 Sep 7.
Chronic Eosinophilic Leukemia Presenting as Cardiac Failure.
Boi-Doku Pepra-Ameyaw N, Ghunney WK, Baafi Ampofo E, Olayemi E.
Case Rep Hematol. 2022 Dec 16;2022:7841310. doi: 10.1155/2022/7841310. eCollection 2022.
Hypereosinophilic Syndrome.
Curtis C, Ogbogu P.
Clin Rev Allergy Immunol. 2016 Apr;50(2):240-51. doi: 10.1007/s12016-015-8506-7.
World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management.
Shomali W, Gotlib J.
Am J Hematol. 2022 Jan 1;97(1):129-148. doi: 10.1002/ajh.26352. Epub 2021 Oct 8.
Myeloproliferative Neoplasms.
Thapa B, Fazal S, Parsi M, Rogers HJ.
2023 Aug 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.
The Diagnostic Work-Up of Hypereosinophilia.
Wang SA.
Pathobiology. 2019;86(1):39-52. doi: 10.1159/000489341. Epub 2018 Jun 29.
The international consensus classification of eosinophilic disorders and systemic mastocytosis.
Wang SA, Orazi A, Gotlib J, Reiter A, Tzankov A, Hasserjian RP, Arber DA, Tefferi A.
Am J Hematol. 2023 Aug;98(8):1286-1306. doi: 10.1002/ajh.26966. Epub 2023 Jun 7.
Charcot-Leyden crystals in chronic eosinophilic leukemia.
Sandberg Y, Weerkamp F.
Blood. 2021 Apr 8;137(14):1985. doi: 10.1182/blood.2020010648.
